New target is an apparent triple threat to pneumonia.
Scientists have evidence that variants of the same gene that enables us to make connective tissue by crosslinking proteins is associated with unusual glaucoma.
Looking at the urine and blood may be best in diagnosing myeloma
New targets found to reduce blood vessel damage in diabetes
MCG students selected to participate in yearlong NIH research program
The cybersecurity and IT-related workforce in the Augusta metro area and Fort Gordon increased from 12,716 to 14,765. These workers contribute more than $1 billion to the local economy in salaries alone.
Scientists explore how high blood pressure hurts cognition.
Oxidative stress can help tumors thrive, but one way novel cancer treatments work is by pushing levels to the point where it instead helps them die, scientists report.
Silence is golden when it comes to how our brains work
When Curt Thompson’s son was diagnosed with a paraganglioma, a tumor from the adrenal gland tissue, he was told that, due to the rarity of his son’s condition, the family would need to travel across the country for treatment. Thompson’s family...
Sullivan selected for two national scientific honors.
When trauma spills the contents of our cell powerhouses, it can evoke a potentially deadly immune response much like a severe bacterial infection.
A cancer researcher is determined to take a family’s gift and turn it into hope for liver cancer patients. For the family, it’s an opportunity to keep the memory of a mother and wife alive for generations to come.
AUGUSTA, Ga. (June 6, 2018) – Immune cells that are first responders to a traumatic brain injury appear to also contribute to the secondary damage that can occur even days later, scientists say. The NETs – or neutrophil extracellular traps – these...
A team of three Georgia Cancer Center researchers is taking the next step towards finding a future treatment option for colorectal cancer, the third leading cause of cancer-related deaths.
Dr. Kathryn Bollinger, ophthalmologist, glaucoma specialist and retinal cell biologist, is working on protections from glaucoma.
What are "wicked" problems, and how do we solve them? One hint: User innovation is key.
Protective protein activated by vitamin K found, inactive, abundant in African-Americans on dialysis
High levels of a protein activated by vitamin K and associated with cardiovascular disease when it isn’t, has been found in the blood of African-Americans on dialysis, investigators report.
A new and early target for treating pulmonary hypertension appears to be an enzyme that’s normally key to energy production but destructive in the face of this high blood pressure inside your lungs.
New research published in Cancer Immunology Research by Drs. Esteban Celis and Hussein Sultan of the Georgia Cancer Center at Augusta University could serve as the stepping-stone in constructing vaccines with a greater likelihood of finding and...
